Cultivation Capital leads $1.3 million Series A for Euclises By: St. Louis Business Journal via Business Journals September 09, 2014 at 12:22 PM EDT Euclises Pharmaceuticals, a biotech startup looking to develop treatments for cancer, has closed on a $1... Read More >> Related Stocks: Monsanto Co Pfizer